Gene expression of inflammatory immune factors and clinical parameters in diabetes and nondiabetes patients with periodontal disease DOI Open Access
Gabriela Alessandra da Cruz Galhardo CAMARGO, Juliane Maria da Silva Rodrigues, Camila Silva de Amorim

et al.

Research Society and Development, Journal Year: 2022, Volume and Issue: 11(1), P. e17711124185 - e17711124185

Published: Jan. 4, 2022

Objective: This study evaluated clinical, glucose, and immunological parameters in patients with type 2 diabetes mellitus (DM) compared to those without systemic alterations (NDM), both generalized chronic periodontitis. Methodology: Twenty-one were selected indications of tooth loss. Surgeries performed using the Widman flap modified obtain a gingival collar at 1 mm from margin. Before surgical procedure, following clinical evaluated: pocket probing depth (PPD), recession (GR), attachment level (CAL), bleeding on (BOP). Fasting glucose levels (FGL) glycosylated hemoglobin Hba1c (HbA1c) also assessed. During surgery, tissue samples collected frozen for later laboratorial analysis. The processed mRNA, cDNA determine gene expression immune IL-1-β, IL-6, TNF-α, IL-10 NF-kB by real-time polymerase chain reaction (RT-PCR). Data analyzed statistically considering p<0.05. Results: BOP, FGL, HbA1c higher DM group. RNAm IL-1β, group (p<0.05). Conclusion: presence hyperglycemic status increase pro-inflammatory factors severity periodontal disease.

Language: Английский

Diabetes mellitus promotes susceptibility to periodontitis—novel insight into the molecular mechanisms DOI Creative Commons

Mingcan Zhao,

Yuandong Xie,

Wenjia Gao

et al.

Frontiers in Endocrinology, Journal Year: 2023, Volume and Issue: 14

Published: Aug. 16, 2023

Diabetes mellitus is a main risk factor for periodontitis, but until now, the underlying molecular mechanisms remain unclear. can increase pathogenicity of periodontal microbiota and inflammatory/host immune response periodontium. Hyperglycemia induces reactive oxygen species (ROS) production enhances oxidative stress (OS), exacerbating tissue destruction. Furthermore, alveolar bone resorption damage epigenetic changes in induced by diabetes may also contribute to periodontitis. We will review latest clinical data on evidence promoting susceptibility periodontitis from epidemiological, mechanistic, potential therapeutic targets discuss possible mechanistic targets, focusing particular novel OS. Understanding intertwined pathogenesis explain cross-interference between endocrine metabolic inflammatory diseases better, provide theoretical basis new systemic holistic treatment, promote interprofessional collaboration physicians dentists.

Language: Английский

Citations

50

Pathogenesis and treatment of wound healing in patients with diabetes after tooth extraction DOI Creative Commons
Shuting Yang, You Li, Chengcheng Liu

et al.

Frontiers in Endocrinology, Journal Year: 2022, Volume and Issue: 13

Published: Sept. 23, 2022

Diabetes mellitus is a common systematic chronic disease amongst dental patients. The elevated glucose microenvironment can prolong the healing of tooth extraction sockets. Therefore, promotion up sockets great clinical importance to patients with diabetes mellitus. current evidence indicates mechanism recovery period in hyperglycaemia conditions from physiological, inflammation, immune, endocrine and neural aspects. New advancements have been made varied curative approaches drugs management wound diabetes. However, most interventions are still stage animal experiments, whether it be put into application needs further explorations. Specifically, our work showed topical administration plasma-rich growth factor, advanced platelet-rich fibrin, leukocyte- fibrin hyaluronic acid as well maxillary immediate complete denture regarded promising approach for diabetic requiring extractions. Overall, recent studies present blueprint new advances novel effective this worldwide health ailment healing.

Language: Английский

Citations

34

Protective effects of curcumin against osteoporosis and its molecular mechanisms: a recent review in preclinical trials DOI Creative Commons

Shenglei Yang,

Yuying Sun,

Л. В. Капилевич

et al.

Frontiers in Pharmacology, Journal Year: 2023, Volume and Issue: 14

Published: Sept. 18, 2023

Osteoporosis (OP) is one of the most common metabolic skeletal disorders and commonly seen in elderly population postmenopausal women. It mainly associated with progressive loss bone mineral density, persistent deterioration microarchitecture, increased fracture risk. To date, drug therapy primary method used to prevent treat osteoporosis. However, long-term inevitably leads resistance specific side effects. Therefore, researchers are constantly searching for new monomer compounds from natural plants. As a candidate treatment osteoporosis, curcumin (CUR) phenolic compound various pharmacological biological activities, including antioxidant, anti-apoptotic, anti-inflammatory. This has gained research attention maintaining health osteoporosis models. We reviewed preclinical clinical studies preventing alleviating These results suggest that if subjected rigorous trials, naturally-derived could be as complementary alternative medicine by targeting osteoporosis-related mechanistic pathways. review summarizes mechanisms action potential therapeutic applications prevention mitigation provides reference further development curcumin.

Language: Английский

Citations

15

HO-1 in Bone Biology: Potential Therapeutic Strategies for Osteoporosis DOI Creative Commons
Xueman Zhou,

Wenxiu Yuan,

Xin Xiong

et al.

Frontiers in Cell and Developmental Biology, Journal Year: 2021, Volume and Issue: 9

Published: Nov. 30, 2021

Osteoporosis is a prevalent bone disorder characterized by mass reduction and deterioration of microarchitecture leading to fragility fracture risk. In recent decades, knowledge regarding the etiological mechanisms emphasizes that inflammation, oxidative stress senescence cells contribute development osteoporosis. Studies have demonstrated heme oxygenase 1 (HO-1), an inducible enzyme catalyzing degradation, exhibits anti-inflammatory, anti-oxidative anti-apoptosis properties. Emerging evidence has revealed HO-1 critical in maintenance homeostasis, making potential target for osteoporosis treatment. this Review, we aim provide introduction current biology its regulation, focusing specifically on roles homeostasis We also examine HO-1-based pharmacological therapeutics issues faced during clinical translation.

Language: Английский

Citations

32

Arrestin beta‐2 deficiency exacerbates periodontal inflammation by mediating activating transcription factor 6 activation and abnormal remodelling of the extracellular matrix DOI
Meiting Feng,

Ruiling Wang,

Li Deng

et al.

Journal Of Clinical Periodontology, Journal Year: 2024, Volume and Issue: 51(6), P. 742 - 753

Published: Jan. 24, 2024

Abstract Aim To investigate the specific role of arrestin beta‐2 (ARRB2) in progression periodontitis and underlying mechanisms. Materials Methods Single‐cell RNA sequencing data were used to analyse gene expression periodontal tissues from healthy controls patients with periodontitis. Real‐time quantitative polymerase chain reaction, Western blotting immunohistochemical staining performed detect ARRB2. Furthermore, a ligature‐induced model was created. Using radiographic histological methods, luciferase assay, ARRB2 mechanisms explored. Finally, therapeutic effect melatonin, an inhibitor activating transcription factor 6 (ATF6), on mice assessed both vivo vitro experiments. Results up‐regulated inflammatory tissue. In mouse model, Arrb2 knockout exacerbated alveolar bone loss (ABL) extracellular matrix (ECM) degradation. exerted negative regulatory ATF6 , essential targeted gene. Melatonin ameliorated ABL imbalance ECM remodelling ‐deficient mice. Conclusions mediates via inhibition signalling pathway, which ultimately exerts protective tissues.

Language: Английский

Citations

4

Jaw osteoporosis: Challenges to oral health and emerging perspectives of treatment DOI Open Access
Fushuang Liu, Xuan Wang,

Yikai He

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 177, P. 116995 - 116995

Published: June 24, 2024

Osteoporosis is a prevalent bone metabolic disease that poses significant challenge to global human health. Jaw osteoporosis, characterized by microstructural damage of the jaw resulting from various factors, one common manifestations this condition. Recent studies have demonstrated osteoporosis has multifaceted effects on oral health and can negatively impact conditions such as periodontitis, implantation, orthodontic treatment, wound healing. However, there are still some limitations in conventional treatment osteoporosis. For instance, while bisphosphonates enhance quality, they may also lead osteonecrosis jaw, which potential safety hazard diagnosis treatment. In recent years, considerable attention been focused improving pathological condition Treatment strategies gut microbial regulation, extracellular vesicles, molecular targeted therapy, herbal medicine, mechanical stimulation expected efficacy minimize adverse reactions. Therefore, understanding these exploring novel treatments for provide new insights maintenance This article reviews describes associated with current methods. It discusses emerging perspectives offering comprehensive overview challenges future directions managing

Language: Английский

Citations

4

Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway DOI Creative Commons
Dianshan Ke, Haoying Xu,

Junyong Han

et al.

Biomedical Journal, Journal Year: 2023, Volume and Issue: 47(1), P. 100605 - 100605

Published: May 11, 2023

Curcumin ameliorates bone loss by inhibiting osteoclastogenesis. inhibits RANKL-promoted autophagy in osteoclast precursors (OCPs), which mediates its anti-osteoclastogenic effect. But the role of RANKL signaling curcumin-regulated OCP is unknown. This study aimed to explore relationship between curcumin, signaling, and during We investigated curcumin RANKL-related molecular OCPs, identified significance RANK-TRAF6 curcumin-treated osteoclastogenesis using flow sorting lentiviral transduction. Tg-hRANKL mice were used observe vivo effects on RANKL-regulated loss, osteoclastogenesis, autophagy. The JNK-BCL2-Beclin1 pathway with was explored via rescue assays BCL2 phosphorylation detection. inhibited repressed differentiation sorted RANK+ OCPs but did not affect those RANK− OCPs. Curcumin-inhibited recovered TRAF6 overexpression. lost these under knockdown. Furthermore, prevented decrease mass increase trabecular formation mice. Additionally, curcumin-inhibited reversed JNK activator anisomycin TAT-Beclin1 overexpressing Beclin1. at Ser70 enhanced protein interaction Beclin1 suppresses downstream RANKL, contributing Moreover, plays an important

Language: Английский

Citations

10

Diabetes, periodontal disease, and novel therapeutic approaches- host modulation therapy DOI Creative Commons
Ying Gu, Lorne M. Golub,

Hsi‐Ming Lee

et al.

Frontiers in Clinical Diabetes and Healthcare, Journal Year: 2025, Volume and Issue: 6

Published: March 3, 2025

Diabetes mellitus is a much-studied disorder, characterized by hyperglycemia and numerous oral medical complications. The latter includes (above all) decreased life-span — these are widely discussed in the dental literature. complications include impaired wound healing; increased severity of periodontal disease peri-implantitis; dry mouth (xerostomia); caries. relationship between diabetes health bi-directional: Optimal management local can profoundly affect systemic metabolic control diabetic patient, strict patient’s reduce its impact on disease. only host modulation therapy (HMT), approved U.S. Food Drug Administration (FDA) to treat disease, novel NON-antimicrobial (low-dose) formulation doxycycline (Periostat ® ; 20 mg b.i.d). A publication Scientific Reports (2017), which supported clinical rationale efficacy safety low-dose diabetics, stated: “doxycycline not ameliorated insulin resistance, fasting blood glucose, levels, lipid profiles circulation liver, but also improved islet morphology glucose-stimulated secretion.” Additional developments biphenolic chemically-modified curcumins, as HMT for managing diseases. lead compound, curcumin 2.24 (CMC2.24), has demonstrated vitro , cell culture, vivo using mouse, rat, rabbit, dog models In conclusion, host-modulation compounds have shown significant promise adjuncts traditional other

Language: Английский

Citations

0

Targeting Epigenetic Plasticity to Reduce Periodontitis-Related Inflammation in Diabetes: CBD, Metformin, and Other Natural Products as Potential Synergistic Candidates for Regulation? A Narrative Review DOI Open Access

Amelia Tero-Vescan,

Mark Slevin,

Amalia Pușcaș

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(7), P. 2853 - 2853

Published: March 21, 2025

Periodontitis is unanimously accepted to be the sixth complication of diabetes mellitus (DM), while inverse relationship causality still deciphered. Among proposed mechanisms gut dysbiosis, which responsible for systemic release proinflammatory mediators. In this process, Gram-negative bacteria from oral cavity enter general circulation, leading emergence bi-hormonal beta-pancreatic cells that lack ability secrete insulin. Additionally, epigenetic and adaptive in affected may play a role reducing inflammation. The reactive oxygen species, cytokines, adipokines, such as interleukins, tumor necrosis factor alpha, leptin, prostaglandin E2, C-reactive protein, or matrix metalloproteinases, determine changes, methylation DNA nucleotides changes activity histone acetylases/deacetylases. management periodontitis involves targeting inflammation, its potential connection modulation observed other chronic conditions help explain preventing DM patients. This review focuses on key might contribute development, explores novel multi-drug therapies could prevent these effects.

Language: Английский

Citations

0

Mitochondrial dysfunction as a key player in aggravating periodontitis among diabetic patients: review of the current scope of knowledge DOI Creative Commons

Al-Hassan Soliman Wadan,

Ahmed Sherief Moshref,

Ahmed Emam

et al.

Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2025, Volume and Issue: unknown

Published: April 24, 2025

Language: Английский

Citations

0